Popular Articles

Abraxis Bioscience Completes Enrollment Of Pivotal Phase III Advanced Lung Cancer Study Evaluating Abraxane(R) Vs. Taxol(R)
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced that the company has completed patient enrollment of a pivotal, phase III clinical study comparing the company"s chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) with Taxol® (paclitaxel) injection, both in combination with carboplatin, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). The study, which is being conducted at 111 sites globally, includes 1,050 patients and is being led by principal investigator Dr. Mark Socinski at the University of North Carolina Lineberger Comprehensive Cancer Center. It is one of the largest NSCLC clinical studies to complete enrollment.
drugs without prescription
Researchers Discover Genetic Cause For Primary Biliary Cirrhosis
Researchers have discovered a novel molecular path that predisposes patients to develop primary biliary cirrhosis, a disease that mainly affects women and slowly destroys their livers. Primary biliary cirrhosis has no known cause.
News of the day
First Mosquitoes Test Positive For West Nile Virus In Southern Illinois
Dr. Damon T. Arnold, state public health director, announced a mosquito batch collected in St. Clair County has been confirmed as the first positive West Nile virus test results in southern Illinois this year.
Sexual Health

Senate Approves Supplemental Spending Bill With Funds For Flu Pandemic

The Senate on Thursday voted 86-3 to approve a $91.3 billion fiscal year 2009 supplemental war appropriations bill (HR 2346) that includes $1.5 billion for influenza pandemic preparedness, the AP/Detroit Free Press reports (Taylor, AP/Detroit Free Press, 5/21). The House already has approved a $96.7 billion version of the measure (H Res 434) (Sanchez, CongressDaily, 5/22). A conference committee to reconcile the two bills will not meet until after lawmakers return from the Memorial Day recess (Stanton/Dennis, Roll Call, 5/21). Senate Majority Leader Harry Reid (D-Nev.) said, "There are very few things that need to be worked out in conference" before the measure is passed (CongressDaily, 5/22). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):